Table 1 Patient characteristics
From: Characterization of immune cells in psoriatic adipose tissue
(n = 30) | Median (IQR) |
|---|---|
Age (years) | 54 (41–61) |
Male, count (%) | 35 (54) |
Psoriasis Disease Duration (years) | 20 (9–32) |
Body Surface Area Score [Mean (SD)] | 9.2 (16) |
PASI Score [Mean (SD)] | 7.8 (9.3) |
Psoriatic Arthritis, count (%) | 25 (38) |
DMARD Therapy, count (%) | 6 (9) |
Biologic Therapy, count (%) | 25 (39) |
NSAID Therapy, count (%) | 15 (23) |
Phototherapy, count (%) | 3 (5) |
Topical Steroid Therapy, count (%) | 24 (37) |
Systemic Steroid Therapy, count (%) | 1 (2) |
Diabetes Mellitus, count (%) | 7 (11) |
Hypertension, count (%) | 21 (32) |
Dyslipidemia, count (%) | 44 (68) |
Current Tobacco Use, count (%) | 6 (9) |
Former Tobacco Use, count (%) | 18 (28) |
Diabetes Mellitus Therapy, count (%) | 4 (6) |
Anti-Hypertensive Therapy, count (%) | 12 (19) |
Dyslipidemia therapy, count (%) | 24 (37) |
Body Mass Index (kg/m2) | 29 (25.9-32.3) |
Systolic Blood Pressure (mm Hg) | 125 (116–135) |
Diastolic Blood Pressure (mm Hg) | 72 (65–78) |
Fasting Blood Glucose (mg/dL) | 94 (89–104) |
Total Cholesterol (mg/dL) | 184 (158–203) |
Triglycerides (mg/dL) | 108 (84–137) |
High-Density Lipoprotein Cholesterol (mg/dL) | 52 (42–63) |
Low-Density Lipoprotein Cholesterol (mg/dL) | 96 (80–125) |
Erythrocyte Sedimentation Rate (mm/hr) | 8 (5–13) |
High-Sensitivity C-Reactive Protein (g/dL) | 1.7 (0.7-4.2) |